Atara Biotherapeutics Inc



-21.7% last 12 months

Market Cap

$1.27 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$11.81 - $21.85

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $1.27 Billion
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return -21.7%
52-Week High $21.85
52-Week Low $11.81
Beta 1.28
Outstanding Shares 88.4 Million
Avg 30 Day Volume 796 Thousand


P/E Ratio 0.0
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -


Revenue -
Gross Profit -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

Insider trades

30,854 shares bought (2 transactions)

50,177 shares sold (10 transactions)

No purchases

25,076 shares sold (7 transactions)

No purchases

33,066 shares sold (6 transactions)

No purchases

5,000 shares sold (1 transactions)

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Atara Biotherapeutics Inc

CEO: Pascal Touchon

Industry: Biological Product (except Diagnostic) Manufacturing

Similar stocks

Applied Genetic Technologies Corp
Applied Genetic Technologies Corp
Agenus Inc
Agenus Inc
Affimed N.V.
Affimed N.V.
Immunogen, Inc.
Immunogen, Inc.